kynurenine has been researched along with Pseudotumor Cerebri in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether the metabolites of Kynurenine pathway (KP) could serve as biomarkers for distinguishing between viral CNS infections and autoimmune neuroinflammatory diseases, especially anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) and herpes virus encephalitis (HSE)." | 4.02 | Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway. ( Luo, Y; Möhn, N; Peßler, F; Senel, M; Skripuletz, T; Stangel, M; Sühs, KW; Tumani, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, Y | 1 |
| Möhn, N | 1 |
| Skripuletz, T | 1 |
| Senel, M | 1 |
| Tumani, H | 1 |
| Peßler, F | 1 |
| Sühs, KW | 1 |
| Stangel, M | 1 |
1 other study available for kynurenine and Pseudotumor Cerebri
| Article | Year |
|---|---|
Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway.
Topics: Adult; Aged; Aged, 80 and over; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Biomarkers; Encepha | 2021 |